‘Teach & Treat’ – Funded IP Training Opportunity
Wednesday 3rd December 2025
This is an exciting opportunity to be part of a regional ‘Teach & Treat’ project, supporting Independent Prescribing (IP) training for community pharmacists in Hertfordshire and West Essex (HWE).
Please read the Teach & Treat FAQs for more details
Funding Available:
- Successful applicants will be provided with a DPP plus additional, quality assured, IP training & support
Eligibility Criteria:
- Intention to Enrol: You must be able to start a GPhC-accredited IP training programme at the University of East Anglia in March 2026
- Hertfordshire and west Essex (HWE) Practice: You must work as a community pharmacist within the HWE area for at least three days per week
- Employer Support: Your employer must provide necessary support for your training, including appropriate cover during your absence (no backfill costs will be covered)
Key Training Considerations:
- Course options: Accredited IP courses typically span six months and combine face-to-face teaching sessions (often one day per week) with self-directed study. For the Teach & Treat project we are working with University of East Anglia; if successful, you’d need to be willing to attend this IP course (course fees covered by NHS England – see below)
- Learning Requirements: All courses necessitate a minimum of 26 days of formal teaching and learning activities. Additionally, you will be required to complete at least 12 days (90 hours) of supervised practice-based learning under the guidance of a DPP
Application Process:
- To apply for this training opportunity, please complete the online expression of interest form by midnight on Sunday 21st December 2025. Please note applications may close earlier depending on interest.
For further information on NHS England-funded IP courses, please visit the NHS England website.
For any inquiries regarding this funding opportunity, please contact Nazia Ismail – Pharmaceutical Advisor – Strategy and Pharmacy Workforce Development
Wednesday 3rd December 2025



